RECALL DATABASE

Semaglutide Recall: Wegovy Injection Pens

Announced 2026-01-07 · FDA

The FDA recall covers Wegovy (semaglutide) Injection pens, 0.5 mg/0.5 mL, 4 single-dose prefilled pens, manufactured by Novo Nordisk A/S and distributed nationwide. The recall is due to the presence of particulate matter, specifically hair, in a prefilled syringe. Affected lots are Lot RZFHD52 and RZFHW93, with expiration date 10/31/2026.

BrandNovo Nordisk Inc.
ProductWegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14
ReasonPresence of Particulate Matter: Hair was found in a prefilled syringe
Severitymoderate
Units affectedN/A
DistributionNationwide within the United States.
AgencyFDA

WHAT YOU SHOULD DO

  1. Do not use Wegovy injection pens from the affected lots (RZFHD52 or RZFHW93).
  2. Check the lot number on your package to confirm if it is affected.
  3. Contact your healthcare provider or Novo Nordisk for replacement guidance and instructions on returning the product.
  4. If you have used the product or have concerns, report them to your healthcare provider.

How to identify the recalled item

Lot / date codesLot #: RZFHD52, RZFHW93; Exp Date 10/31/2026
Lot / date codesLot #: RZFYK06, RZFYA53; Exp Date 3/31/2027

These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.

Other semaglutide recalls

See every semaglutide recall →

This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.